Golden
Demetrix

Demetrix

Demetrix is a biotechnology company that uses genes found in natural medicines and introduces them to domesticated microbes, for example, the synthetic production of certain chemicals. Demetrix was founded by Dr Haseltine and Jay Keasling.

Dr. Haseltine is the CEO of Demetrix and was previously professor and founder of two departments at Harvard Medical School, one on HIV/AIDS and one on cancer biology. Dr. Haseltine led Human Genome Sciences, one of the first companies to apply genetics to treat disease, and founded several other biotechnology companies. Dr. Haseltine leads the Haseltine Foundation for Science and the Arts, and ACCESS Health International, both non-profits in health and the humanities.



Demetrix is named after Demeter, the greek goddess of the harvest.

Timeline

Funding rounds

1 Result
Funding round
Funding round
Funding round amount (USD)
Funding round amount (USD)
Funding type
Funding type
Funding round date
Funding round date
Investment
Investment

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References